Product correctly added to cart.

Irinotecan-d10 Hydrochloride (Major)
View 3D

Biosynth logo

Irinotecan-d10 Hydrochloride (Major)

CAS: 718612-62-5

Ref. 3D-TDB61262

1mgDiscontinued
5mgDiscontinued
10mgDiscontinued
25mgDiscontinued
50mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
Irinotecan-d10 Hydrochloride (Major)
Description:

Irinotecan is a chemotherapeutic drug used in the treatment of colon, lung and breast cancers. It is an anti-cancer drug that blocks the synthesis of DNA by inhibiting the enzyme topoisomerase I. Irinotecan-d10 hydrochloride (major) is a water soluble form of irinotecan which has been radiolabeled with the radioactive isotope d10. This form of irinotecan has been shown to be more toxic than other forms because it does not require activation by carboxylesterases in the liver, allowing for direct delivery to tumor tissue. Irinotecan-d10 hydrochloride (major) can be used to visualise cancer cells with bioluminescence imaging and can also be used to determine if tumor cells are sensitive or resistant to chemotherapy by measuring changes in expression of factor receptors.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
633.2 g/mol
Formula:
C33H29D10ClN4O6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-TDB61262 Irinotecan-d10 Hydrochloride (Major)

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".